Skip to main content
. 2020 Feb 24;15(2):e0229260. doi: 10.1371/journal.pone.0229260

Table 4. Descriptive statistics of the glaucoma subgroup receiving a surgical intervention.

Glaucoma 1st surgery (n = 27) Glaucoma 2nd surgery (n = 10)
MIGS (n = 16) TE (n = 9) CPC (n = 2) Trabectome (n = 2) TE (n = 8)
Age (years) 62.8±12.4 52.1±19.7 52.5±31.8 60.5±13.4 55.9±12.8
Gender (male/female) 16 (100%)/0 (0%) 8 (88.9%)/ 1 (11.1%) 2 (100%)/0 (0%) 2 (100%)/ 0 (0%) 8 (100%)/0 (0%)
Side (right/left) 9 (56.2%)/7 (43.8%) 5 (55.6%)/4(44.4%) 1 (50.0%)/1 (50.0%) 0 (0%)/2 (100%) 5 (62.5%)/3 (37.5%)
Virus RV 7 (43.8%) 4 (44.4%) 0 (0%) 1 (50.0%) 3 (37.5%)
CMV 4 (25.0%) 2 (22.2%) 0 (0%) 1 (50.0%) 2 (25.0%)
HSV 3 (18.8%) 1 (11.1%) 1 (50.0%) 0 (0%) 1 (12.5%)
VZV 1 (6.3%) 1 (11.1%) 1 (50.0%) 0 (0%) 2 (25.0%)
MV 1 (6.3%) 1 (11.1%) 0 (0%) 0 (0%) 0 (0%)
pre-Op VA (logMAR) 0.21±0.38 0.75±0.20 0.30±0.71 0.70±0.14 0.40±0.36
pre-Op IOP (mmHg) 28.40±9.63 28.00±9.96 27.00±8.49 30.50±13.43 27.75±9.48
Number of glaucoma medications 1.88±0.89 2.00±1.00 2.00±0.00 2.00 ± 0.00 2.25±1.04

CPC = cyclophotocoagulation, CMV = cytomegalovirus, HSV = herpes simplex virus, MIGS = minimal-invasive glaucoma surgery, MV = multiple virus, TE = trabeculectomy, VA = visual acuity, VZV = varicella-zoster virus